AAAAAA
Results: 26-37/37
Authors:
Nemetz, A
Nosti-Escanilla, MP
Molnar, T
Kope, A
Kovacs, A
Feher, J
Tulassay, Z
Nagy, F
Garcia-Gonzalez, MA
Pena, AS
Citation: A. Nemetz et al., IL1B gene polymorphisms influence the course and severity of inflammatory bowel disease, IMMUNOGENET, 49(6), 1999, pp. 527-531
Authors:
Rostami, K
Mulder, CJJ
Werre, JM
van Beukelen, FR
Kerckhaert, J
Crusius, JBA
Pena, AS
Willekens, FLA
Meijer, JWR
Citation: K. Rostami et al., High prevalence of celiac disease in apparently healthy blood donors suggests a high prevalence of undiagnosed celiac disease in the Dutch population, SC J GASTR, 34(3), 1999, pp. 276-279
Authors:
Nemetz, A
Kope, A
Molnar, T
Kovacs, A
Feher, J
Tulassay, Z
Nagy, F
Garcia-Gonzalez, MA
Pena, AS
Citation: A. Nemetz et al., Significant differences in the interleukin-1 beta and interleukin-1 receptor antagonist gene polymorphisms in a Hungarian population with inflammatory bowel disease, SC J GASTR, 34(2), 1999, pp. 175-179
Authors:
Schrijver, HM
Crusius, JBA
Uitdehaag, BMJ
Gonzalez, MAG
Kostense, PJ
Polman, CH
Pena, AS
Citation: Hm. Schrijver et al., Association of interleukin-1 beta and interleukin-1 receptor antagonist genes with disease severity in MS, NEUROLOGY, 52(3), 1999, pp. 595-599
Authors:
Pena, AS
Citation: As. Pena, Crossing borders in IBD - Clinical symposium - Barcelona, October 2, 1998 - Preface, DRUGS TODAY, 35, 1999, pp. 1-2
Authors:
Hawkey,"Pena, AS",Hanauer,Kruis,Rutgeerts,Cortot,Tremaine,Stockbrugger,Rolny,Ornly,Panes,Gassull,Cohen,Pena
Citation: Hawkey,"pena, As",hanauer,kruis,rutgeerts,cortot,tremaine,stockbrugger,rolny,ornly,panes,gassull,cohen,pena, How to prevent a flare-up in ulcerative colitis - Discussion, DRUGS TODAY, 35, 1999, pp. 139-143
Authors:
Dijkhuizen, AC
Sprenger, N
Pena, AS
Citation: Ac. Dijkhuizen et al., Videoconferencing in a clinical setting, DRUGS TODAY, 35, 1999, pp. 145-147
Authors:
Pena, AS
Meuwissen, SGM
Falke, TJM
Cuesta, MA
Hanauer, SB
Rutgeerts, P
Tremaine, BW
Gassull, MA
Cortot, A
Cohen, Z
Citation: As. Pena et al., Inflammatory bowel disease. A case presentation from Amsterdam with a panel discussion in Barcelona, DRUGS TODAY, 35, 1999, pp. 149-159
Authors:
Bouma, G
Crusius, JBA
Garcia-Gonzalez, MA
Meijer, BUGA
Hellemans, HPR
Hakvoort, RJ
Schreuder, GMT
Kostense, PJ
Meuwissen, SGM
Pena, AS
Citation: G. Bouma et al., Genetic markers in clinically well defined patients with ulcerative colitis (UC), CLIN EXP IM, 115(2), 1999, pp. 294-300
Authors:
Garcia-Gonzalez, MA
Pena, AS
Citation: Ma. Garcia-gonzalez et As. Pena, Nitric oxide and inflammatory bowel disease., REV ESP E D, 90(12), 1998, pp. 870-876
Authors:
Pena, AS
Citation: As. Pena, Genetics of inflammatory bowel disease - The candidate gene approach: Susceptibility versus disease heterogeneity, DIGEST DIS, 16(6), 1998, pp. 356-363
Authors:
Dieleman, LA
Palmen, MJHJ
Akol, H
Bloemena, E
Pena, AS
Meuwissen, SGM
van Rees, EP
Citation: La. Dieleman et al., Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines, CLIN EXP IM, 114(3), 1998, pp. 385-391